Article Versions Notes

Ammendola S, Caldonazzi N, Rizzo PC, Turri G, Pedrazzani C, Barresi V. H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma. Biomedicines. 2022; 10(8):2042. https://doi.org/10.3390/biomedicines10082042

Ammendola, Serena, Nicolò Caldonazzi, Paola Chiara Rizzo, Giulia Turri, Corrado Pedrazzani, and Valeria Barresi. 2022. "H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma" Biomedicines 10, no. 8: 2042. https://doi.org/10.3390/biomedicines10082042

Ammendola, S., Caldonazzi, N., Rizzo, P. C., Turri, G., Pedrazzani, C., & Barresi, V. (2022). H3K27me3 Immunohistochemical Loss Predicts Lower Response to Neo-Adjuvant Chemo-Radiotherapy in Rectal Carcinoma. Biomedicines, 10(8), 2042. https://doi.org/10.3390/biomedicines10082042